CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence

CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence

Abstract Background Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide. Specific and thorough identification of cancer cell subsets with higher tumorigenicity and chemoresistance, such as cancer stem cells (CSCs), could lead to the development of new and promising therapeutic...

Full description

Bibliographic Details
Main Authors: Angel A. Gómez-Gallegos, Lizbeth Ramírez-Vidal, Jared Becerril-Rico, Elizabeth Pérez-Islas, Zuly J. Hernandez-Peralta, Mariel E. Toledo-Guzmán, Alejandro García-Carrancá, Elizabeth Langley, Angélica Hernández-Guerrero, Fernando López-Casillas, Roberto Herrera-Goepfert, Luis F. Oñate-Ocaña, Elizabeth Ortiz-Sánchez
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Stem Cell Research & Therapy
Subjects:
Gastric cancer
Cancer stem cells
Immunophenotype
Metastasis
Zebrafish
Xenotransplants
Online Access:https://doi.org/10.1186/s13287-023-03241-7

Internet

https://doi.org/10.1186/s13287-023-03241-7

Similar Items